Literature DB >> 12763585

Expression of a member of tumor necrosis factor receptor superfamily, TROY, in the developing mouse brain.

Tomoko Hisaoka1, Yoshihiro Morikawa, Toshio Kitamura, Emiko Senba.   

Abstract

TROY is a recently identified member of the tumor necrosis factor (TNF) receptor superfamily. We investigated the expression pattern of TROY mRNA in the developing central nervous system by the in situ hybridization technique. TROY mRNA was strongly expressed in the ventricular zone and the subventricular zone, which contain neuronal and glial precursors during mouse embryogenesis. Its spatial and temporal expression patterns suggest that TROY plays some important roles in neurogenesis of embryonic stages.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12763585     DOI： 10.1016/s0165-3806(03)00101-9

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN： 0165-3806


  14 in total

1.  Inhibition of TROY promotes OPC differentiation and increases therapeutic efficacy of OPC graft for spinal cord injury.

Authors:  Liang Sun; Shengliang Liu; Qi Sun; Zhuying Li; Fengyan Xu; Chunmei Hou; Toshihide Harada; Ming Chu; Kun Xu; Xiaoling Feng; Yongshun Duan; Yafang Zhang; Shuliang Wu
Journal:  Stem Cells Dev       Date:  2014-06-16       Impact factor: 3.272

Review 2.  p75NTR and TROY: Uncharted Roles of Nogo Receptor Complex in Experimental Autoimmune Encephalomyelitis.

Authors:  Paschalis Theotokis; Nikolaos Grigoriadis
Journal:  Mol Neurobiol       Date:  2018-01-02       Impact factor: 5.590

3.  Tumor necrosis factor receptor superfamily member 19 (TNFRSF19) regulates differentiation fate of human mesenchymal (stromal) stem cells through canonical Wnt signaling and C/EBP.

Authors:  Weimin Qiu; Yuhui Hu; Tom E Andersen; Abbas Jafari; Na Li; Wei Chen; Moustapha Kassem
Journal:  J Biol Chem       Date:  2010-03-11       Impact factor: 5.157

4.  TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signaling.

Authors:  Vincent M Paulino; Zhongbo Yang; Jean Kloss; Matthew J Ennis; Brock A Armstrong; Joseph C Loftus; Nhan L Tran
Journal:  Mol Cancer Res       Date:  2010-09-29       Impact factor: 5.852

Review 5.  The Anti-inflammation Property of Olfactory Ensheathing Cells in Neural Regeneration After Spinal Cord Injury.

Authors:  Chao Jiang; Xiaohui Wang; Yizhen Jiang; Zhe Chen; Yongyuan Zhang; Dingjun Hao; Hao Yang
Journal:  Mol Neurobiol       Date:  2022-08-13       Impact factor: 5.682

6.  A Novel Signaling Complex between TROY and EGFR Mediates Glioblastoma Cell Invasion.

Authors:  Zonghui Ding; Alison Roos; Jean Kloss; Harshil Dhruv; Sen Peng; Patrick Pirrotte; Jennifer M Eschbacher; Nhan L Tran; Joseph C Loftus
Journal:  Mol Cancer Res       Date:  2017-11-08       Impact factor: 5.852

7.  TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance.

Authors:  Joseph C Loftus; Harshil Dhruv; Serdar Tuncali; Jean Kloss; Zhongbo Yang; Cassie A Schumacher; Brian Cao; Bart O Williams; Jennifer M Eschbacher; Julianna T D Ross; Nhan L Tran
Journal:  Mol Cancer Res       Date:  2013-05-22       Impact factor: 5.852

8.  Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathway.

Authors:  Harshil D Dhruv; Alison Roos; Patrick J Tomboc; Serdar Tuncali; Ashley Chavez; Ian Mathews; Michael E Berens; Joseph C Loftus; Nhan L Tran
Journal:  J Neurooncol       Date:  2015-11-12       Impact factor: 4.130

Review 9.  The role of tumor necrosis factor receptor superfamily members in mammalian brain development, function and homeostasis.

Authors:  Jason P Twohig; Simone M Cuff; Audrey A Yong; Eddie C Y Wang
Journal:  Rev Neurosci       Date:  2011-08-24       Impact factor: 4.353

10.  Identification of Wnt/β-catenin modulated genes in the developing retina.

Authors:  Andrew Ha; Carol Perez-Iratxeta; Hong Liu; Alan J Mears; Valerie A Wallace
Journal:  Mol Vis       Date:  2012-03-16       Impact factor: 2.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.